Companies researching Keytruda (pembrolizumab)
Keytruda (pembrolizumab) is a humanized monoclonal antibody used in cancer immunotherapy to treat melanoma, lung, head‑and‑neck, Hodgkin lymphoma, stomach, cervical and certain breast cancers, administered via intravenous infusion.
45
companies
List of companies that research Keytruda (pembrolizumab)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
Employees428Biotechnology ResearchKeytruda (pembrolizumab)High confidence
Employees386Biotechnology ResearchKeytruda (pembrolizumab)High confidence
Employees277Revenue$17MMedical PracticesKeytruda (pembrolizumab)Low confidence
Employees3.7kRevenue$15MPharmaceutical ManufacturingKeytruda (pembrolizumab)Low confidence
Employees6.2kHospitals and Health CareKeytruda (pembrolizumab)Low confidence- Employees97Revenue$18MBusiness Consulting and ServicesKeytruda (pembrolizumab)Low confidence
Employees1.3kFinancial ServicesKeytruda (pembrolizumab)Low confidence
Employees21kRevenue$5.5BHospitals and Health CareKeytruda (pembrolizumab)Low confidence
Employees1kRevenue$4.2MHospitals and Health CareKeytruda (pembrolizumab)Low confidence
Employees10kRevenue$3.8MHospitals and Health CareKeytruda (pembrolizumab)Low confidence
Showing top companies out of 45 that research Keytruda (pembrolizumab). Get the full list on TheirStack.
Frequently asked questions